143 related articles for article (PubMed ID: 8548418)
1. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.
van den Berg M; Stehouwer CD; Bierdrager E; Rauwerda JA
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):165-71. PubMed ID: 8548418
[TBL] [Abstract][Full Text] [Related]
2. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
Robinson K; Arheart K; Refsum H; Brattström L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I
Circulation; 1998 Feb; 97(5):437-43. PubMed ID: 9490237
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
4. Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.
Bostom AG; Gohh RY; Tsai MY; Hopkins-Garcia BJ; Nadeau MR; Bianchi LA; Jacques PF; Rosenberg IH; Selhub J
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1894-900. PubMed ID: 9351351
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease.
Bergmark C; Mansoor MA; Swedenborg J; de Faire U; Svardal AM; Ueland PM
Eur J Vasc Surg; 1993 Jul; 7(4):391-6. PubMed ID: 8359294
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
Robinson K; Gupta A; Dennis V; Arheart K; Chaudhary D; Green R; Vigo P; Mayer EL; Selhub J; Kutner M; Jacobsen DW
Circulation; 1996 Dec; 94(11):2743-8. PubMed ID: 8941098
[TBL] [Abstract][Full Text] [Related]
7. Plasma homocysteine and severity of thoracic aortic atherosclerosis.
Tribouilloy CM; Peltier M; Iannetta Peltier MC; Trojette F; Andrejak M; Lesbre JP
Chest; 2000 Dec; 118(6):1685-9. PubMed ID: 11115459
[TBL] [Abstract][Full Text] [Related]
8. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC
Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698
[TBL] [Abstract][Full Text] [Related]
10. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
Graham IM; Daly LE; Refsum HM; Robinson K; Brattström LE; Ueland PM; Palma-Reis RJ; Boers GH; Sheahan RG; Israelsson B; Uiterwaal CS; Meleady R; McMaster D; Verhoef P; Witteman J; Rubba P; Bellet H; Wautrecht JC; de Valk HW; Sales Lúis AC; Parrot-Rouland FM; Tan KS; Higgins I; Garcon D; Andria G
JAMA; 1997 Jun; 277(22):1775-81. PubMed ID: 9178790
[TBL] [Abstract][Full Text] [Related]
12. Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women.
Dierkes J; Kroesen M; Pietrzik K
Int J Vitam Nutr Res; 1998; 68(2):98-103. PubMed ID: 9565824
[TBL] [Abstract][Full Text] [Related]
13. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
Taylor LM; Moneta GL; Sexton GJ; Schuff RA; Porter JM
J Vasc Surg; 1999 Jan; 29(1):8-19; discussion 19-21. PubMed ID: 9925456
[TBL] [Abstract][Full Text] [Related]
14. Betaine and folate status as cooperative determinants of plasma homocysteine in humans.
Holm PI; Ueland PM; Vollset SE; Midttun Ø; Blom HJ; Keijzer MB; den Heijer M
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):379-85. PubMed ID: 15550695
[TBL] [Abstract][Full Text] [Related]
15. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations.
van der Griend R; Biesma DH; Haas FJ; Faber JA; Duran M; Meuwissen OJ; Banga JD
J Intern Med; 2000 Sep; 248(3):223-9. PubMed ID: 10971789
[TBL] [Abstract][Full Text] [Related]
16. Low vitamin B6, and not plasma homocysteine concentration, as risk factor for abdominal aortic aneurysm: a retrospective case-control study.
Peeters AC; van Landeghem BA; Graafsma SJ; Kranendonk SE; Hermus AR; Blom HJ; den Heijer M
J Vasc Surg; 2007 Apr; 45(4):701-5. PubMed ID: 17398378
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
18. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
[TBL] [Abstract][Full Text] [Related]
20. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Smulders YM; Rakic M; Slaats EH; Treskes M; Sijbrands EJ; Odekerken DA; Stehouwer CD; Silberbusch J
Diabetes Care; 1999 Jan; 22(1):125-32. PubMed ID: 10333913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
